个人简介
Silvia Nozza是IRCCS圣拉斐尔科学研究医院Turro分院传染病科的传染病医生,在Antonella Castagna教授的指导下开展工作。Nozza医生是预防和疫苗接种职能部门的负责人。
1998年,Nozza医生从毕业于米兰大学医学学院,2004年在米兰的圣拉斐尔生命健康大学获得传染病学专业学位。
在临床方面,Nozza医生十分擅长HIV、新型冠状病毒感染和疫苗接种;此外,她在预防HIV感染、性传播感染防治方面具有相当丰富的经验。
至于研究方面,Nozza医生是INACTION(意大利急性HIV感染研究网络)的主要研究员,协调该组织在意大利境内20个中心的工作;此外,她还是GEPPO(HIV/AIDS老年患者)研究的主要研究员,这是一项未来可期的多维HIV/AIDS研究。
Nozza医生还在意大利国内外期刊上以作者或共同作者的身份发表了多篇科研论文。多次参加国际上的各种行业学术会议。
出版物
最新出版物
Anti-Tat immunity defines CD4+ Tcell dynamics in people living with HIV on long-term cART
EBioMedicine. 2021 Mar 30:103306. doi: 10.1016/j.ebiom.2021.103306. Epub ahead of print. PMID: 33839064.
Residual viremia in HIV-infected patients who continue a 2-drug or switch to a 3-drug integrase strand transfer inhibitor-based regimen.
AIDS. 2021 Apr 6. doi: 10.1097/QAD.0000000000002908. Epub ahead of print. PMID: 33831909.
Dolutegravir is not associated with weight gain in antiretroviral therapy experienced geriatric patients living with HIV.
AIDS. 2021 May 1;35(6):939-945. doi: 10.1097/QAD.0000000000002853. PMID: 33635844.
Icona Foundation Cohort. The impact of DAA-mediated HCV eradication on CD4+ and CD8+ T lymphocyte trajectories in HIV/HCV coinfected patients: Data from the ICONA Foundation Cohort
J Viral Hepat. 2021 Feb 18. doi: 10.1111/jvh.13488. Epub ahead of print. PMID: 33600068.
Exercise ECG for coronary artery disease screening in people living with HIV.
AIDS. 2021 May 1;35(6):933-938. doi: 10.1097/QAD.0000000000002828. PMID: 33534202.
ICONA Foundation Study Group. HBcAb Positivity Increases the Risk of Severe Hepatic Fibrosis Development in HIV/HCV-Positive Subjects From the ICONA Italian Cohort of HIV-Infected Patients.
Open Forum Infect Dis. 2020 Nov 18;8(1):ofaa566. doi: 10.1093/ofid/ofaa566. PMID: 33447635; PMCID: PMC7781466
Italian Society of Infectious and Tropical Diseases. Therapeutic strategies for severe COVID-19: a position paper from the Italian Society of Infectious and Tropical Diseases (SIMIT).
Clin Microbiol Infect. 2021 Mar;27(3):389-395. doi: 10.1016/j.cmi.2020.12.011. Epub 2021 Jan 18. PMID: 33359375; PMCID: PMC7833273
Allogeneic bone marrow transplantation in HIV people with hematological malignancies: Post-transplant cyclophosphamide to overcome the HLA-matching barrier
Transpl Infect Dis. 2020 Dec 22:e13551. doi:10.1111/tid.13551. Epub ahead of print. PMID: 33351984
COVID-BioB study group. Viral clearance after early corticosteroid treatment in patients with moderate or severe covid-19.
Sci Rep. 2020 Dec 4;10(1):21291. doi: 10.1038/s41598-020-78039-1. PMID: 33277573; PMCID: PMC7718220
COVID-BioB study group. Secondary infections in patients hospitalized with COVID-19: incidence and predictive factors.
Clin Microbiol Infect. 2021 Mar;27(3):451-457. doi:10.1016/j.cmi.2020.10.021. Epub 2020 Oct 24. PMID: 33223114; PMCID: PMC7584496.